<DOC>
	<DOC>NCT00273468</DOC>
	<brief_summary>To study the safety and effectiveness of a granisetron patch to treat Chemotherapy-Induced Nausea and Vomiting (CINV)</brief_summary>
	<brief_title>To Study the Safety and Effectiveness of a Granisetron Patch to Treat Chemotherapy-Induced Nausea and Vomiting (CINV)</brief_title>
	<detailed_description />
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Granisetron</mesh_term>
	<criteria>Patients must be of nonchildbearing potential and female patients must have a negative pregnancy test at the Screening Visit Histologically and/or cytologically confirmed cancer with ECOG ≤2 Life expectancy of ≥ 3 months Assigned to receive the first cycle of a new multiday chemotherapy regimen including the daily administration of cytotoxic agent(s) with the emetogenic potential of level 35 (Hesketh Classification) on 35 days Hypersensitivity to adhesive plasters Contraindications to 5HT3 receptor antagonists Clinically relevant abnormal laboratory values or hepatic, renal, infectious, neurological or psychiatric disorders or any other major systemic illness at the discretion of the Investigator Any cause for nausea and vomiting other than CINV Clinically relevant abnormal ECG parameters Concomitant radiotherapy of total body, brain or upper abdomen within one week of study entry or planned during the study A patient taking a medication to control the symptoms of a brain tumour, brain metastasis or seizure disorder</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
</DOC>